dichloroacetate   Click here for help

GtoPdb Ligand ID: 4518

Abbreviated name: DCA
Synonyms: dichloroacetic acid
Compound class: Synthetic organic
Comment: Dichloroacetate (DCA) is an orally available small molecule pyruvate dehydrogenase kinase inhibitor [4]. It acts as a metabolic regulator and has anti-cancer potential by promoting glucose oxidation over glycolysis, glycolysis being the metabolic pathway (Warburg effect) utilised by most cancer cells to resist apoptosis and gain proliferative advantage [1-3].
ChEMBL represents this compound without the charge (see link above).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 1
Topological polar surface area 40.13
Molecular weight 126.94
XLogP 0.09
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ClC(C(=O)[O-])Cl
Isomeric SMILES ClC(C(=O)[O-])Cl
InChI InChI=1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)/p-1
InChI Key JXTHNDFMNIQAHM-UHFFFAOYSA-M
References
1. James MO, Jahn SC, Zhong G, Smeltz MG, Hu Z, Stacpoole PW. (2017)
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
Pharmacol Ther, 170: 166-180. [PMID:27771434]
2. Kankotia S, Stacpoole PW. (2014)
Dichloroacetate and cancer: new home for an orphan drug?.
Biochim Biophys Acta, 1846 (2): 617-29. [PMID:25157892]
3. Michelakis ED, Webster L, Mackey JR. (2008)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
Br J Cancer, 99 (7): 989-94. [PMID:18766181]
4. Sutendra G, Michelakis ED. (2013)
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology.
Front Oncol, 3: 38. [PMID:23471124]